Glenmark Life Sciences' Stock Soars, Outperforms Sector and Sensex with Strong Growth
Glenmark Life Sciences, a midcap pharmaceutical company, has gained attention in the stock market with a 5.36% increase in its stock on October 1st. The company's consecutive 3-day rise and positive moving averages indicate its growth and potential. It has also outperformed the Sensex in both short and long term performances.
Glenmark Life Sciences, a midcap pharmaceutical company, has been making headlines in the stock market with its recent performance. On October 1st, the company's stock gained 5.36%, outperforming the sector by 5.94%. This positive trend has caught the attention of MarketsMOJO, who have given a 'Buy' call for the stock.
The stock has been on a consecutive gain for the last 3 days, with a rise of 9.82% in this period. It also touched an intraday high of Rs 1115.05, showing a 5.36% increase. This is a strong indication of the company's growth and potential in the market.
Glenmark Life Sciences' moving averages are also showing a positive trend, with all averages (5 day, 50 day, 100 day, and 200 day) higher than the stock's current price. However, it is lower than the 20 day moving average, which could be a potential area for improvement.
In comparison to the Sensex performance, Glenmark Life Sciences has outperformed with a 1 day performance of 5.26% while the Sensex has shown a -0.06% performance. Similarly, in the last 1 month, the company's performance has been 5.99% compared to the Sensex's 2.29%.
Overall, Glenmark Life Sciences is showing strong growth and potential in the pharmaceutical industry. With a 'Buy' call from MarketsMOJO and a positive performance in the stock market, it is definitely a company to keep an eye on.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
